HomeCompareWUXIF vs MO

WUXIF vs MO: Dividend Comparison 2026

WUXIF yields 0.94% · MO yields 6.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WUXIF wins by $3.60M in total portfolio value
10 years
WUXIF
WUXIF
● Live price
0.94%
Share price
$13.88
Annual div
$0.13
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.68M
Annual income
$3,055,751.48
Full WUXIF calculator →
MO
Altria Group Inc.
● Live price
6.36%
Share price
$65.99
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.1K
Annual income
$30,159.17
Full MO calculator →

Portfolio growth — WUXIF vs MO

📍 WUXIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWUXIFMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WUXIF + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WUXIF pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WUXIF
Annual income on $10K today (after 15% tax)
$79.61/yr
After 10yr DRIP, annual income (after tax)
$2,597,388.76/yr
MO
Annual income on $10K today (after 15% tax)
$540.99/yr
After 10yr DRIP, annual income (after tax)
$25,635.29/yr
At 15% tax rate, WUXIF beats the other by $2,571,753.46/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WUXIF + MO for your $10,000?

WUXIF: 50%MO: 50%
100% MO50/50100% WUXIF
Portfolio after 10yr
$1.88M
Annual income
$1,542,955.32/yr
Blended yield
82.01%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

WUXIF
No analyst data
Altman Z
9.8
Piotroski
7/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-7.2% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WUXIF buys
0
MO buys
0
No recent congressional trades found for WUXIF or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWUXIFMO
Forward yield0.94%6.36%
Annual dividend / share$0.13$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%22.6%
Portfolio after 10y$3.68M$80.1K
Annual income after 10y$3,055,751.48$30,159.17
Total dividends collected$3.61M$74.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: WUXIF vs MO ($10,000, DRIP)

YearWUXIF PortfolioWUXIF Income/yrMO PortfolioMO Income/yrGap
1← crossover$10,887$187.32$10,570$780.30+$317.00WUXIF
2$12,031$381.20$11,381$1,032.90+$650.00WUXIF
3$13,660$787.34$12,535$1,392.73+$1.1KWUXIF
4$16,287$1,671.00$14,193$1,920.91+$2.1KWUXIF
5$21,152$3,724.08$16,618$2,723.68+$4.5KWUXIF
6$31,672$9,039.75$20,263$3,993.80+$11.4KWUXIF
7$59,190$25,300.84$25,936$6,098.36+$33.3KWUXIF
8$151,713$88,379.99$35,166$9,775.01+$116.5KWUXIF
9$585,758$423,425.00$51,026$16,597.78+$534.7KWUXIF
10$3,682,512$3,055,751.48$80,113$30,159.17+$3.60MWUXIF

WUXIF vs MO: Complete Analysis 2026

WUXIFStock

WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.

Full WUXIF Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this WUXIF vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WUXIF vs SCHDWUXIF vs JEPIWUXIF vs OWUXIF vs KOWUXIF vs MAINWUXIF vs PMWUXIF vs BTIWUXIF vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.